DatasetName,PANK2_S(168) PANK2_S(191) PANK2_S(203) PANK2_S(45) PANK2_T(182) PANK2_Y(190),PANK2_S(165) PANK2_S(169) PANK2_S(171) PANK2_S(189) PANK2_S(215) PANK2_S(3) PANK2_S(46) PANK2_S(5) PANK2_S(66)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.4517727684484454,
FSO2013_Ratio M/L normalized Rep3,0.47650824323047475,0.6123899886207077
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5670375036142326
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.4390238874142391,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.4534383068945776,0.5095603716782542
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.486006003795393,0.5580095081720455
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.4552636496632392,0.5673293470731595
DB2022_Intensity L2,,0.5470873135810131
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.453848262695677,0.509803906744398
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.4716241733265986,0.5565802511098424
RB2022_5_PreEndurance,0.404661732633185,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,0.45674810785719505,0.5550628360798553
EP2017_Untreated R#4 normalized log2 ratio,0.4413624779496009,0.5662299410986599
WZ2023_Pu_010_30min,0.4864439800102793,0.6106210074805651
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.4587496158488292,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5816793828205231
RB2022_8_RecoveryEndurance,,0.5601884316991641
KBE2022_Log2_Ex_14_U,0.438426975092202,0.5579926094261594
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.544544159555994
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.4296706518548821,0.5425267329250785
AH2018_SILAC_MR_2_N,,0.5798624986186448
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.47198763530955584,0.5636552679568421
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.5580729429692656
UK2020_HCM_2,,0.5602891616570891
FSO2013_Ratio H/L normalized Rep2___2,0.3980320782465685,0.5211876767342605
EP2017_Pervanadate R#3 normalized log2 ratio,0.47230294573467035,0.5604547220642329
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.46396096113139423,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.4966597354585023,0.5737247232145847
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.4844612415104452,0.6128677348400249
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.45234527667584895,0.5643759127333886
WZ2023_Pu_005_10min,0.49295286569926483,0.6131215223459763
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.44543349225933576,0.5519340824560097
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.49964622608481735,0.6030911196771468
AH2018_SILAC_MR_2_X,,0.5810738061269857
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4411186105648328,0.5475728475232917
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.4569518135857011,
EJN2021_3_Rest_Basal,0.45685501934802586,0.5662650943478418
CR2017_Ratio Replicate 1.3,0.44134949400266105,0.5376530269036129
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.573607039323451
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5694094582813642
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.48171254231294497,0.568783740230496
AH2018_LFQ_1_C,,0.5756445860729951
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.45701183909850346,0.5594190795884558
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.4826990943933844,0.6124824027868958
CK2022_11 40-1,0.44857060276267147,0.552761578367407
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.56950645256016
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5545940560993865
FSO2013_Ratio H/L normalized Rep2,0.45355120188144027,0.5301909722441748
WZ2023_Pu_005_20min,0.4928461003513301,0.6160548804084827
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.4492033629161491,0.5452892375235381
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,0.46169015691421933,0.5627062530046372
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5777860149084763
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,0.5428652779019867
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.4613663709296822,0.5569184743825626
PG2020_Intensity Mock_10h_D,0.4538695280077983,0.5561098378311347
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.46601872291974944,0.5354604663807492
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.4426798277881463,0.5408327911238979
PG2020_Intensity 2h_C,0.44284136439153493,0.5309217126596041
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.4582597512985119,0.5649053987522533
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.45810282922317924,0.559071002629376
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.579161854526249
CK2022_3 40-1,0.4388647362891913,0.5551406169753073
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5624652471355188
HH2022_Reporter intensity 8,,0.5690985312416255
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.554718946644655
EJN2021_5_Rest_Basal,0.44915891760569765,0.5655842936602833
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5734562671147585
YA2020_Reporter_intensity_Normal_No.1,0.45052753182530764,0.5619188805825454
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,0.4584256219586522,
CR2017_Ratio Replicate 3,0.4396546743974897,0.5344942301632324
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.4634718088920069,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.4887667826382711,0.5599361711312143
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5775802577880202
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,0.44159923376135835,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4914073812613395,0.5985936840161815
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.439672101134916,0.5541661511927833
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,0.5495411452394379
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5733660338332738
FSO2013_Ratio H/M normalized Rep2,0.4875205117537857,0.6103429510079859
RAM2015_Log2 A,,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.5482111057977984
KS2014_Intensity E15_2,,0.5530399925385345
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5311406486741777
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5738308790963421
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.45676129836012686,0.571928811252788
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5763517383052026
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.45402937367423674,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.4412817499623906,0.5659820567509405
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.45238174557532984,0.5624684276761546
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.5677532252132687
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.44365361358479327,
AH2018_SILAC_IT_3_X,,0.5717602211225539
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.46680253635986557,0.578285286742839
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5701576921596598
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.4552235408945448,0.5582880973117709
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.457644918682475,0.5568397764169644
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5763727314285438
DL2023_control-1,0.43309675867921155,
AR2021_ALG 10 μM,0.4955742857696796,0.5832051826566655
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.576051998702177
EJN2021_4_Rest_Ins,0.44223172694059354,0.5678194540854489
RN2012_H05,,0.5839175727864838
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.45920987187791623,0.5543385609774183
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.45088839296390804,0.5716174772756202
HH2022_Reporter intensity 3,,0.5590583496423234
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.567690407594569
JW2021_After_3,,
GF2025_P8_Sph,0.4970829295449635,0.5739277877675799
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5691333721295243
CK2022_11 200-1,0.4606199628538281,0.5539884123186553
CK2022_12 200-1,0.4619810295154656,0.555892185978488
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.5701887719109967
WZ2023_Su_010_20min,0.49252610006371106,0.6172826893757872
AH2018_TMTMS2_2_N,,0.5476670397081917
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.45170570898625945,0.5659533101660359
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.5634971740267517
AH2018_TMTMS3_Pool,,0.5476733966293991
KS2014_Intensity N4,,0.5505671192390285
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.5600062259519935
CK2022_14 200-1,0.45980390249012776,0.5599989313702722
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.43587780376943813,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5549811031716853
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.44926604561488737,0.5533415367419292
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.4603743730642333,0.5705085023350249
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.4566395830238446,0.5635596730420211
GF2025_P1_Sph,0.4573596388835015,0.5556147385647523
EJN2021_5_Ex_Basal,0.44538353899788613,0.5655763146589641
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.4865599865611661,0.5957571358985796
CF2017_EOC 1,,0.570962396534671
CK2022_3 200-1,0.45928945481077066,0.5580663170897859
AH2018_LFQ_IT_3_C,,0.5683170775618444
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.5534454967626367
RB2022_3_RecoverySprint,0.46626475057384315,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.44219658939752177,0.55376292286777
RB2022_1_PostSprint,0.4362310326242092,
CK2022_4 200-1,0.4583697938157121,0.5557987934568728
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.514835449347017,0.597344256246227
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.46040005866227957,0.5662099660160386
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.47125743982034396,0.5690826054895071
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.4740192286550511,0.5642168612881293
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.4597324046752964,0.5597003792687416
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.5537583369165362
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,0.45500518534478,0.5562063233116624
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.49628478948356053,0.6216303165702839
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.45063168719761576,0.5639153128237395
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5694580478958888
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5512328611663542
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.4442452171506878,0.5633116903119104
AH2018_LFQ_M_1_N,,0.5824408661084858
KBE2022_Log2_Ex_27_U,0.45106131859658394,0.5607632696361661
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5734031108473416
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.5644616675626954
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.462025862482028,0.5531382898223579
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.5444509456537009
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.46829848469562013,0.5601475047176194
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.4890225656450113,0.6116734336644857
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.4435154178869647,0.5525523705718843
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.45424372455238976,0.5895769532899447
HH2022_Reporter intensity 6,,0.5691314179314687
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.38053291466936984,0.554990725848929
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5493306325677336
GF2025_P3_Adh,0.48108596386038566,0.581464849345814
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5457852180627776
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.4617020085326469,0.5410890313423219
KBE2022_Log2_Ex_19_U,0.44493489394189406,0.5669241800021269
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.45440924646399505,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,0.5648000920096695
YA2020_Reporter_intensity_Cancer_No.1,,0.5669467663372098
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,0.56624116633789
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,0.45570981183015496,0.5608570309658371
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.46653617954557774,0.5775349648526071
LG2023_Control-2_intensity,,0.5755883410460674
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.46443779032962657,0.5686678734031512
RB2022_7_RecoverySprint,0.4410029289048378,0.5612729495274409
YA2020_Reporter_intensity_Normal_No.3,,0.5609228250430892
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.5796651626338516
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.551438456152945
HH2022_Reporter intensity 1,,0.5577785955063176
HH2022_Reporter intensity 2,,0.5582036540541468
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.563558718461706
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.49096625301301433,0.5694680885453227
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.5749255772653404
CR2017_Ratio Replicate 2,0.4742310185354907,0.5762335376445824
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.4719911671881481,0.5745640040857372
AR2021_KD 72h,0.48182086409318076,0.5501179166712669
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.46805944773960784,0.5634229336289445
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5502248385611219
KBE2022_Log2_Ex_9_U,0.44407986766264934,0.5661869638792348
AH2018_SILAC_M_3_N,,0.573705330966347
KBE2022_Log2_Ex_13_T,0.4452286673895867,0.563149821185364
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.45695394827336305,0.5534931045595672
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.448537132585225,0.5436071845015923
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5715093949869607
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.4863086634974539,0.6076545117966501
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.5578037812665004
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.43750107872514277,0.5538070521260442
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.4500606808822041,0.5673813217598731
TM2022_S2.12h.B,,
RN2012_L15,,0.5801378311359909
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.45984795378134563,0.5583835861653949
FSO2013_Ratio H/M normalized Rep2___2,0.4943981326861235,0.585431713027297
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.45275504402751815,0.5662868717968581
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.4528217118466911,0.5541546384863694
CK2022_5 200-1,0.4542574522888538,0.5548960208881009
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,0.4686619496281051,0.5650991377405314
FSO2013_Ratio H/L normalized Rep2___1,0.4537510911097571,0.5301464161312726
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5770312747338138
AH2018_SILAC_MR_1_X,,0.5804711583102358
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.45265421614088314,0.5642660299471585
AH2018_SILAC_3_C,,0.5715536487264155
EJN2021_5_Rest_Ins,0.44314699404748187,0.5692066301000681
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.48564872334982323,0.6070921732614066
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.45654176041103556,0.571501676575928
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5806831008759136
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.529410591666421
FSO2013_Ratio H/L normalized Rep3,0.448368952526584,0.5255797670384457
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.44235697916268907,0.5646166674333054
AH2018_SILAC_IT_2_N,,0.5762019345639944
AH2018_SILAC_IT_1_X,,0.571082084320675
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.5615099148838208
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.4826183114759588,0.569268927877462
WZ2023_Pe_025_20min,0.48599444557098925,0.6125268840236017
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.578670192332667
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.5504874015701645
RN2012_H06,,0.5828364810341529
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.4989823093104482,0.6213467423903798
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.5612784067381812
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.46181396162173444,0.5251488517516356
WZ2023_Su_025_10min,0.5006728223235072,0.6242196739670188
AH2018_LFQ_IT_4_X,,0.5735852604614122
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.4568363063851913,0.5777105674744106
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.49723058657027225,0.621815068519424
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.5634446112564572
EP2017_Pervanadate R#1 log2 ratio,0.46315219054988876,0.5625176755855122
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.5535945494332262
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5468236354005274
LY2019_P7+,0.49420223417783893,0.5608672755384645
EP2017_Untreated R#1 normalized log2 ratio,0.4931241268323716,0.571270050068033
RN2012_L10,,
PG2020_Intensity 4h_C,0.442036654053503,0.5545997831770677
EP2017_Mitotic R#3 normalized log2 ratio,0.4666055172368606,0.5332323796248478
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,0.5362299696277468
KBE2022_Log2_Ex_24_T,0.45380635318362694,0.5667642444543022
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.5721136479208488
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.4509893452676259,0.5619777202692364
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.43496472321904717,0.564287738375944
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,0.4570241729717935,0.5498488204343601
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.45957117672170833,0.5605048556596545
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.46684906412282845,0.5401261381104607
GF2025_P9_Sph,0.4856605288390588,0.5560153012633524
CK2022_6 200-1,0.45303321237067173,0.5542601514970096
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5436045926106847
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.42824839470550596,0.549235199758464
EP2017_Untreated R#3 normalized log2 ratio,0.46384899942123764,0.5515941411369447
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.4530944699955979,0.5542770883547563
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.4245242106579867,0.5312132953339319
RB2022_7_PostEndurance,0.4524922284600244,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,0.56812108923044
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.4810984927383508,0.5662809819178637
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,0.4567336715453007,0.5645545672390656
AH2018_SILAC_2_C,,0.5683811294615845
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.4427881334599369,0.5662364224061109
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.4567755553308383,0.5692458559383078
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.5826105453917215
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.4531680919559289,0.550312107708076
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.4541228590592998,0.5658122686213617
EP2017_Untreated R#3 log2 ratio,0.46354000009241186,0.5514102336904151
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.41981692608044335,0.5272843550551414
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,0.45270423735965126,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.45003955613936397,0.5647669741223308
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.4458124738945157,0.5498935133332251
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.4607973122571119,0.5582619277602707
YA2020_Reporter_intensity_Normal_No.2,,0.5633574074059756
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5804964232207082
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4375647141065009,0.5626132897252166
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.45288488818808187,0.568046673054793
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.5621630391333023
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,0.41646241699470626,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.44206839899613676,0.5504702557393801
WZ2023_Su_025_30min,0.49958289217033425,0.6258707405070024
AH2018_LFQ_4_N,,0.5808974266064983
CR2017_Ratio Replicate 1.2,0.45766992543905877,0.554339339261463
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.5714541368478074
AH2018_SILAC_M_1_X,,0.5741128235530097
RB2022_7_PreEndurance,0.4709623324267353,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.43467737698072484,
LY2019_P6+,0.4067913491996747,0.5708340175849267
DB2022_LFQ intensity R2,,0.5459861668660511
GF2025_P6_Adh,0.4559496012431392,0.5491633106517235
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5528273273304115
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.46441772384804286,0.5449260005995472
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.582826515221616
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.424522925861561,0.5427688722492441
AH2018_LFQ_2_X,,0.5773721441639567
PG2020_Intensity 2h_B,,0.5397711763662646
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.4453803078108351,
KS2014_Intensity E15_3,,0.5572144090032293
GF2025_P3_Sph,0.4698123992972591,0.5615660084925681
DB2022_LFQ intensity L2,,0.5400911378449035
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5670492036431912
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.5630135108216551
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5744195354959593
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.45074095906703265,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.47007439000863616,0.5493326423633657
ZQ2022_N1,,
LY2019_P6-,0.3884113262075161,0.5765923090777468
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.561544534086235
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5810327005039047
AH2018_LFQ_3_N,,0.5805739054651069
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,0.5626256477269997
KBE2022_Log2_Ex_13_U,0.4589683902122377,0.5574011853793601
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.45417232119519974,0.577223359190032
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,0.4608183346278132,0.5592626110512667
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.43467585206915677,0.5545313377225584
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.43754995801694846,0.5585629243042693
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,0.54247998043019
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.45221811403049256,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5005197375557674,0.6278803933671901
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.47251051444963316,0.5525032750528737
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,0.4603596136571497,0.5565863932862423
FSO2013_Ratio H/L normalized Rep1,0.4797624802753397,0.5661455420260335
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,0.4603432870021928,0.557022193047758
CK2022_13 40-1,0.45592746962472247,0.5567981184069288
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.445644227475465,0.5662915279977503
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.4501137781981786,0.5693655439497514
EP2017_Pervanadate R#3 log2 ratio,0.46955495259643215,0.556572555570731
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.5818189489544954
AH2018_LFQ_M_4_C,,0.5792482553478439
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,0.535422661183748
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.5637139018077626
RN2012_H04,,0.5939917937482365
CK2022_6 40-1,0.4403882876263203,0.5530659603852492
DB2022_LFQ intensity R2.1,,0.5436727256389836
KBE2022_Log2_Ex_42_U,0.4494884493111053,0.5625921956667054
LY2019_P3-,0.47432688847117216,0.5815237401097516
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.44591424592970014,0.5705158801827267
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.4890907178910382,0.6079119110718425
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.4551889467946189,0.5681534033419996
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.43237143545036916,0.5365620317181751
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.4931211019677222,0.6212650640058451
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.4604620436154967,0.5485554260432952
RB2022_1_RecoveryStrength,0.45102518779607853,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5466990101928827
RB2022_4_PreSprint,,
DB2022_Intensity R2,,0.5438460335511712
AH2018_TMTMS2_Pool,,0.5550041619908197
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5693683936586179
LY2019_P8+,0.4700470251615143,0.5486150862485182
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.45765358458872957,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.5627876689756902
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5797762759382293
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.4552770493341603,0.560008214165745
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5636419174793249
LY2019_P2-,0.48252735818447245,0.5479829573406865
AH2018_LFQ_IT_1_X,,0.5741183051397039
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,0.4715154990055715,0.5817989275203654
WZ2023_Pe_005_20min,0.48453361898901454,0.6102844952870571
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.4405300495653997,0.5538091100468443
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5737359288663115
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.4640838283652851,0.5634969097534626
AH2018_TMTMS3_3_N,,0.5538498681851671
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5777036581479503
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4642215414004928,0.5296677379324068
KBE2022_Log2_Ex_36_T,0.4612695534164129,0.565433904678518
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.49055552529993424,0.6201549053963668
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,0.3980068637572572,0.5211708670747196
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.4528233928779874,0.5660441359950539
CK2022_9 200-1,0.459366076181046,0.5537940678377592
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.45865497484485845,0.5543069904770727
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.45575235665727737,0.5324762995017405
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.4462102916861259,0.5305447923993688
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,0.46060138973488446,0.5568464220755622
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.44734537332140406,0.5696731324102741
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.4552893976765871,0.5629032084174201
FSO2013_Ratio H/M normalized Rep3___2,0.45289671136676196,0.5577640988143894
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.493063834884606,0.5710800317949208
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.49384980389414695,0.6012335510029382
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.5453740759440113
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4404161786426981,0.5512077832406899
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,0.46339145027446377,0.558759274214212
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.5808464726875155
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5820175453623622
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.4467864466137592,0.5590256999503915
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.47412912088443643,0.5544345837157033
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.4848087174548474,0.6058497879496163
KBE2022_Log2_Ex_29_U,0.44580306904722117,0.5663336332725076
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5799812744242786
AH2018_LFQ_IT_4_N,,0.5734230807906271
CK2022_15 200-1,0.4608203691054756,0.5597125342947173
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.45340317629476345,0.563804431221317
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.45003156034315345,
LY2019_P2+,0.4369119032342638,0.5895115584006921
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.46050956352752354,0.557466244774962
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.49463587568355044,0.596567997273896
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.46918834714301233,0.5671273727745195
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.46635416381106776,0.565946959966031
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5622459820853737
KBE2022_Log2_Ex_44_U,0.45436981698411794,0.5687115236411828
WZ2023_Pe_010_20min,0.4863175784642706,0.6080472689199219
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.5637355985310893
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.5493570154911264
FSO2013_Ratio H/M normalized Rep3___1,0.47204323049472036,0.5745672015638008
AH2018_SILAC_M_3_C,,0.5717704789946412
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5687250905265889
AH2018_SILAC_M_2_X,,0.5688988662639585
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.451961541570103,0.5679811282107649
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.4967181381606036,0.6196728440613192
PG2020_Intensity 6h_C,,0.5466094609332102
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5826001894786061
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.5488103183114119
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.479487035340146,0.5223442824244758
FSO2013_Ratio H/L normalized Rep3___2,0.4352180542820275,0.5459783274245664
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.46543928120784545,0.5590795954718546
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.48007152720469254,0.5649068411096834
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5674694007410006
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,0.5373824407507581
DB2022_Intensity R1,,0.5453461421619203
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.5606820328912943
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4627756433604069,0.5342674075530401
EJN2021_2_Ex_Basal,0.45057800108744933,0.5648480596695848
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.564753919435929
CF2017_FTE 16,,0.5676730870588276
AR2021_L41 10 μM,0.4993575322876828,0.5900156380105553
CF2017_EOC 2,,0.5751885649969768
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5733415895033889
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.561426478610661
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.5578579264384586
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.4364605178701711,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5453822167954399
AR2021_L41 1 μM,0.513438157094145,0.596095277243444
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.5485403053836531
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,0.5353490810299573
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.4583761624673528,0.5659644971268876
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5805422386004613
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,0.5581350401179667
YA2020_Reporter_intensity_Cancer_No.2,0.45005428955582133,0.5621814735551403
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.41376197834866585,
AH2018_SILAC_IT_3_C,,0.5739794716438431
WZ2023_Pu_025_10min,0.49611199956693247,0.6176089301097764
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.4759524293747184,0.6116905679855128
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.5735257561017038
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.4870824681666284,0.6070720996577417
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5690902378739755
KS2014_Intensity C6,,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.44855639355045973,0.5539371119740543
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.4571744641763798,0.5574773267716825
AH2018_SILAC_IT_2_C,,0.5747633583840579
CK2022_5 40-1,0.4385943537146401,0.5545398440043718
AH2018_LFQ_3_X,,0.5777110986636086
UK2020_UA_3,,0.5609754740071639
LY2019_P7-,0.5091632457843461,0.5744708346065754
GF2025_P5_Adh,0.47097419552437375,0.555492890549923
RB2022_1_PostStrength,0.4288695844003301,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.44869997975445997,0.5259791135127935
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.4720801311520395,0.5685355711941515
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5150299949700367,0.5940955786103513
PG2020_Intensity CT_B,0.4201877667705869,0.5520062681119555
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5793959372846573
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.5540236389590629
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.5750972133171963
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5818377398891469
YA2020_Reporter_intensity_Cancer_No.4,,0.5639925386040936
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.4746722846419326,0.5721829646069639
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.4541479283299723,0.5656858418753584
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.4544934371568082,0.5511628729258198
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.4953960790161145,0.5860970105806245
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,0.5764757083132412
EP2017_Mitotic R#2 log2 ratio,0.46230016820409475,0.5303556980303283
AH2018_TMTMS2_1_X,,0.546280495329031
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.4449271279705967,0.5672635715177072
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,0.5670676930668063
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,0.5614116699125803
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5660980898382957
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5740940967295982
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,0.5519182172731598
CF2017_FTE 14,,0.5625225504075269
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.44319281739107536,0.5527704222350727
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.4411491417423438,0.5535486921443402
EP2017_Untreated R#2 normalized log2 ratio,0.4911680835546905,0.5697786744150845
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,0.5386050573486459
LY2019_P5+,0.4543054861799544,0.5647488967924967
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.47914905435894733,0.562354632753379
AS2011_Ratio H/L Normalized RNAi_2_1,,
